These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 38675142)

  • 1. Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport.
    Gandhi S; Shastri DH; Shah J; Nair AB; Jacob S
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
    Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
    Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations.
    Koo J; Lim C; Oh KT
    Int J Nanomedicine; 2024; 19():1767-1807. PubMed ID: 38414526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
    Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
    Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges.
    Kashyap K; Shukla R
    Curr Drug Deliv; 2019; 16(10):887-901. PubMed ID: 31660815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
    Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
    J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal delivery of neurotherapeutics
    Rajput A; Pingale P; Dhapte-Pawar V
    Front Pharmacol; 2022; 13():979682. PubMed ID: 36176429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in brain targeting drug delivery system by nasal route.
    Khan AR; Liu M; Khan MW; Zhai G
    J Control Release; 2017 Dec; 268():364-389. PubMed ID: 28887135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders.
    Agosti E; Zeppieri M; Antonietti S; Battaglia L; Ius T; Gagliano C; Fontanella MM; Panciani PP
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent expansions of novel strategies towards the drug targeting into the brain.
    Alexander A; Agrawal M; Uddin A; Siddique S; Shehata AM; Shaker MA; Ata Ur Rahman S; Abdul MIM; Shaker MA
    Int J Nanomedicine; 2019; 14():5895-5909. PubMed ID: 31440051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting.
    Wong CYJ; Baldelli A; Tietz O; van der Hoven J; Suman J; Ong HX; Traini D
    Int J Pharm; 2024 Apr; 654():123922. PubMed ID: 38401871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid Nanoparticles for Nasal/Intranasal Drug Delivery.
    Cunha S; Amaral MH; Lobo JMS; Silva AC
    Crit Rev Ther Drug Carrier Syst; 2017; 34(3):257-282. PubMed ID: 28845761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoemulsions for "Nose-to-Brain" Drug Delivery.
    Bonferoni MC; Rossi S; Sandri G; Ferrari F; Gavini E; Rassu G; Giunchedi P
    Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Nose to Brain Nano Delivery for Effective Management of Migraine.
    Tanna V; Sawarkar SP; Ravikumar P
    Curr Drug Deliv; 2023; 20(2):144-157. PubMed ID: 35366772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Delivery Systems and Strategies to Overcome the Barriers of Brain.
    Garg Y; Kapoor DN; Sharma AK; Bhatia A
    Curr Pharm Des; 2022; 28(8):619-641. PubMed ID: 34951356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.
    Selvaraj K; Gowthamarajan K; Karri VVSR
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2088-2095. PubMed ID: 29282995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.
    Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Patel RJ; Ajazuddin ; Ravichandiran V; Murty US; Alexander A
    J Control Release; 2020 May; 321():372-415. PubMed ID: 32061621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cell-Based Nasal Model for Screening the Deposition, Biocompatibility, and Transport of Aerosolized PLGA Nanoparticles.
    Maaz A; Blagbrough IS; De Bank PA
    Mol Pharm; 2024 Mar; 21(3):1108-1124. PubMed ID: 38333983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.